{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:28:02Z","timestamp":1787498882965,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":368,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Global Medical Genetics"],"published-print":{"date-parts":[[2024]]},"DOI":"10.1055\/s-0044-1779665","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T19:52:32Z","timestamp":1707767552000},"page":"48-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Identification of Novel Risk Variants of Inflammatory Factors Related to Myeloproliferative Neoplasm: A Bidirectional Mendelian Randomization Study"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8966-2215","authenticated-orcid":false,"given":"Yang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3997-6062","authenticated-orcid":false,"given":"Ting","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7096-1056","authenticated-orcid":false,"given":"Jia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7769-7377","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"23","key":"10.1055\/s-0044-1779665_bib1","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood-2017-06-782037","article-title":"Myeloproliferative neoplasms: from origins to outcomes","volume":"130","author":"Nangalia","year":"2017","journal-title":"Blood"},{"issue":"22","key":"10.1055\/s-0044-1779665_bib2","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1182\/blood-2015-01-621110","article-title":"Molecular insights into regulation of JAK2 in myeloproliferative neoplasms","volume":"125","author":"Silvennoinen","year":"2015","journal-title":"Blood"},{"issue":"01","key":"10.1055\/s-0044-1779665_bib3","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13045-020-00995-y","article-title":"Novel therapeutics in myeloproliferative neoplasms","volume":"13","author":"Venugopal","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"08","key":"10.1055\/s-0044-1779665_bib4","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.stem.2022.06.012","article-title":"Inflammatory exposure drives long-lived impairment of hematopoietic stem cell self-renewal activity and accelerated aging","volume":"29","author":"Bogeska","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"13","key":"10.1055\/s-0044-1779665_bib5","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.cell.2022.04.039","article-title":"Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells","volume":"185","author":"Omer-Javed","year":"2022","journal-title":"Cell"},{"issue":"01","key":"10.1055\/s-0044-1779665_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13045-021-01116-z","article-title":"Molecular pathogenesis of the myeloproliferative neoplasms","volume":"14","author":"Greenfield","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1055\/s-0044-1779665_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/648090","article-title":"The role of reactive oxygen species in myelofibrosis and related neoplasms","volume":"2015","author":"Bj\u00f8rn","year":"2015","journal-title":"Mediators Inflamm"},{"issue":"01","key":"10.1055\/s-0044-1779665_bib8","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ccell.2017.11.009","article-title":"Dual targeting of oncogenic activation and inflammatory signaling increases therapeutic efficacy in myeloproliferative neoplasms","volume":"33","author":"Kleppe","year":"2018","journal-title":"Cancer Cell"},{"issue":"16","key":"10.1055\/s-0044-1779665_bib9","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1182\/blood.2022017578","article-title":"Genetic basis and molecular profiling in myeloproliferative neoplasms","volume":"141","author":"Luque Paz","year":"2023","journal-title":"Blood"},{"issue":"06","key":"10.1055\/s-0044-1779665_bib10","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1158\/2159-8290.CD-20-1353","article-title":"LKB1\/STK11 is a tumor suppressor in the progression of myeloproliferative neoplasms","volume":"11","author":"Marinaccio","year":"2021","journal-title":"Cancer Discov"},{"issue":"01","key":"10.1055\/s-0044-1779665_bib11","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1016\/S2352-3026(21)00343-4","article-title":"Symptom burden and quality of life in patients with high-risk essential thrombocythaemia and polycythaemia vera receiving hydroxyurea or pegylated interferon alfa-2a: a post-hoc analysis of the MPN-RC 111 and 112 trials","volume":"9","author":"Mazza","year":"2022","journal-title":"Lancet Haematol"},{"issue":"R1","key":"10.1055\/s-0044-1779665_bib12","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"04","key":"10.1055\/s-0044-1779665_bib13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2018.4175","article-title":"Assessment of bidirectional relationships between physical activity and depression among adults: a 2-sample Mendelian randomization study","volume":"76","author":"Choi","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"05","key":"10.1055\/s-0044-1779665_bib14","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.ajhg.2018.09.009","article-title":"Genome analyses of >200,000 individuals identify 58 loci for chronic inflammation and highlight pathways that link inflammation and complex disorders","volume":"103","author":"Ligthart","year":"2018","journal-title":"Am J Hum Genet"},{"issue":"01","key":"10.1055\/s-0044-1779665_bib15","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ajhg.2016.11.007","article-title":"Genome-wide association study identifies 27 loci influencing concentrations of circulating cytokines and growth factors","volume":"100","author":"Ahola-Olli","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"7831","key":"10.1055\/s-0044-1779665_bib16","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41586-020-2786-7","article-title":"Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells","volume":"586","author":"Bao","year":"2020","journal-title":"Nature"},{"issue":"06","key":"10.1055\/s-0044-1779665_bib17","first-page":"1961","article-title":"Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic","volume":"45","author":"Bowden","year":"2016","journal-title":"Int J Epidemiol"},{"issue":"10","key":"10.1055\/s-0044-1779665_bib18","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1002\/ijc.34214","article-title":"Causal relationships between inflammatory factors and multiple myeloma: a bidirectional Mendelian randomization study","volume":"151","author":"Wang","year":"2022","journal-title":"Int J Cancer"},{"issue":"03","key":"10.1055\/s-0044-1779665_bib19","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.kint.2020.04.044","article-title":"A bidirectional Mendelian randomization study supports causal effects of kidney function on blood pressure","volume":"98","author":"Yu","year":"2020","journal-title":"Kidney Int"},{"issue":"02","key":"10.1055\/s-0044-1779665_bib20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/ije\/dyv080","article-title":"Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression","volume":"44","author":"Bowden","year":"2015","journal-title":"Int J Epidemiol"},{"issue":"04","key":"10.1055\/s-0044-1779665_bib21","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/ije\/dyt110","article-title":"Power and sample size calculations for Mendelian randomization studies using one genetic instrument","volume":"42","author":"Freeman","year":"2013","journal-title":"Int J Epidemiol"},{"issue":"18","key":"10.1055\/s-0044-1779665_bib22","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1182\/bloodadvances.2022007128","article-title":"Hematopoietic fitness of JAK2V617F myeloproliferative neoplasms is linked to clinical outcome","volume":"6","author":"Abu-Zeinah","year":"2022","journal-title":"Blood Adv"},{"issue":"08","key":"10.1055\/s-0044-1779665_bib23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1600-0463.2011.02754.x","article-title":"The JAK2V617F allele burden and STAT3- and STAT5 phosphorylation in myeloproliferative neoplasms: early prefibrotic myelofibrosis compared with essential thrombocythemia, polycythemia vera and myelofibrosis","volume":"119","author":"Risum","year":"2011","journal-title":"APMIS"},{"issue":"03","key":"10.1055\/s-0044-1779665_bib24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1158\/2159-8290.CD-14-0736","article-title":"JAK-STAT pathway activation in malignant and nonmalignant cells contributes to MPN pathogenesis and therapeutic response","volume":"5","author":"Kleppe","year":"2015","journal-title":"Cancer Discov"},{"issue":"10","key":"10.1055\/s-0044-1779665_bib25","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1200\/JCO.2010.32.9490","article-title":"Circulating interleukin (IL)-8, IL-2R, IL-12, and IL-15 levels are independently prognostic in primary myelofibrosis: a comprehensive cytokine profiling study","volume":"29","author":"Tefferi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"03","key":"10.1055\/s-0044-1779665_bib26","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1097\/HS9.0000000000000371","article-title":"Longitudinal cytokine profiling identifies GRO-\u03b1 and EGF as potential biomarkers of disease progression in essential thrombocythemia","volume":"4","author":"\u00d8bro","year":"2020","journal-title":"HemaSphere"},{"issue":"16","key":"10.1055\/s-0044-1779665_bib27","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa2118828","article-title":"Two phase 3, randomized, controlled trials of ruxolitinib cream for vitiligo","volume":"387","author":"Rosmarin","year":"2022","journal-title":"N Engl J Med"},{"issue":"02","key":"10.1055\/s-0044-1779665_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3324\/haematol.2010.031070","article-title":"Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3","volume":"96","author":"Barbui","year":"2011","journal-title":"Haematologica"},{"issue":"12","key":"10.1055\/s-0044-1779665_bib29","doi-asserted-by":"crossref","first-page":"3506","DOI":"10.1007\/s10620-016-4322-z","article-title":"A macrophage migration inhibitory factor polymorphism is associated with autoimmune hepatitis severity in US and Japanese patients","volume":"61","author":"Assis","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1055\/s-0044-1779665_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.108024","article-title":"Macrophage migration inhibitory factor (MIF): a multifaceted cytokine regulated by genetic and physiological strategies","volume":"233","author":"Sumaiya","year":"2022","journal-title":"Pharmacol Ther"},{"issue":"Suppl 1","key":"10.1055\/s-0044-1779665_bib31","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1007\/s10875-012-9781-1","article-title":"MIF alleles, and prospects for therapeutic intervention in autoimmunity","volume":"33","author":"Bucala","year":"2013","journal-title":"J Clin Immunol"},{"key":"10.1055\/s-0044-1779665_bib32","unstructured":"<Macrophage Migration Inhibitory Factor Gene Polymorphism. pdf>."},{"issue":"07","key":"10.1055\/s-0044-1779665_bib33","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/ijc.34281","article-title":"CD25: a potential tumor therapeutic target","volume":"152","author":"Peng","year":"2023","journal-title":"Int J Cancer"},{"issue":"23","key":"10.1055\/s-0044-1779665_bib34","doi-asserted-by":"crossref","first-page":"7046","DOI":"10.1158\/1078-0432.CCR-06-1571","article-title":"A phase2 study of rituximab in combination with recombinant interleukin-2 for rituximab-refractory indolent non-Hodgkin's lymphoma","volume":"12","author":"Khan","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1055\/s-0044-1779665_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.mehy.2018.03.007","article-title":"IL-2\/IL-3 interplay mediates growth of CD25 positive acute myeloid leukemia cells","volume":"115","author":"Nakase","year":"2018","journal-title":"Med Hypotheses"},{"issue":"10","key":"10.1055\/s-0044-1779665_bib36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00018-022-04514-9","article-title":"The present and future of immunocytokines for cancer treatment","volume":"79","author":"Gout","year":"2022","journal-title":"Cell Mol Life Sci"},{"issue":"01","key":"10.1055\/s-0044-1779665_bib37","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.gendis.2021.08.004","article-title":"CCL5\/CCR5 axis in human diseases and related treatments","volume":"9","author":"Zeng","year":"2022","journal-title":"Genes Dis"},{"issue":"07","key":"10.1055\/s-0044-1779665_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12071765","article-title":"The CCL5\/CCR5 axis in cancer progression","volume":"12","author":"Aldinucci","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"08","key":"10.1055\/s-0044-1779665_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081824","article-title":"Chemokines as a conductor of bone marrowmicroenvironment in chronic myeloid leukemia","volume":"18","author":"Mukaida","year":"2017","journal-title":"Int J Mol Sci"},{"issue":"03","key":"10.1055\/s-0044-1779665_bib40","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3324\/haematol.2018.196725","article-title":"CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth","volume":"104","author":"Casagrande","year":"2019","journal-title":"Haematologica"},{"issue":"06","key":"10.1055\/s-0044-1779665_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12062384","article-title":"The relationship of CCL5 and CCR1 variants with response rate and survival taking into account thalidomide\/bortezomib treatment in patients with multiple myeloma","volume":"12","author":"Popek-Marciniec","year":"2023","journal-title":"J Clin Med"},{"issue":"02","key":"10.1055\/s-0044-1779665_bib42","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.bcp.2009.08.006","article-title":"Involvement of matrix metalloproteinase-3 in CCL5\/CCR5 pathway of chondro-sarcomas metastasis","volume":"79","author":"Tang","year":"2010","journal-title":"Biochem Pharmacol"},{"issue":"12","key":"10.1055\/s-0044-1779665_bib43","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.4049\/jimmunol.1201018","article-title":"Tumor-infiltrating mono-cytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth","volume":"189","author":"Schlecker","year":"2012","journal-title":"J Immunol"}],"container-title":["Global Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2699940425000104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2699940425000104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0044-1779665.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T07:36:51Z","timestamp":1761205011000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2699940425000104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":43,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"alternative-id":["S2699940425000104"],"URL":"https:\/\/doi.org\/10.1055\/s-0044-1779665","relation":{},"ISSN":["2699-9404"],"issn-type":[{"value":"2699-9404","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Novel Risk Variants of Inflammatory Factors Related to Myeloproliferative Neoplasm: A Bidirectional Mendelian Randomization Study","name":"articletitle","label":"Article Title"},{"value":"Global Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1055\/s-0044-1779665","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2024 International Knowledge Direct Medical Associations. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}